IEEE

Improving Early Detection and Classification of Lung Diseases With Innovative MobileNetV2 Framework

Abstract: Any condition that damages or impedes the normal operation of the lungs is classified as a lung disease, and failure to identify and address it early can potentially lead to false outcomes.
IEEE

An Explainable and Lightweight Deep Learning Model with Attention Mechanism for Efficient Lung Disease Detection

Abstract: COVID-19 has rapidly spread across the world as an extremely contagious disease. Therefore, early detection of the virus is essential to effectively control its transmission and prevent ...
Frontiers

Case Report: Pediatric Erdheim-Chester disease with bilateral chorioretinal and central nervous system infiltration

Erdheim-Chester disease (ECD) is a rare histiocytic disorder characterized by the infiltration of tissues with foamy, xanthomatous CD68/CD163-positive, CD1a-negative histiocytosis. Pediatric ECD with ...
Reuters

AstraZeneca drug reduces flare-ups of chronic lung disease in late-stage trials

Rival treatments had mixed results in the past AstraZeneca sees $3-5 billion peak annual sales for its drug Detailed results to be presented at upcoming medical conference Shares among biggest gainers ...
The Guardian

From the lab to clinical trials – why a preventative lung cancer vaccine could soon be a reality

Paid content is paid for and controlled by an advertiser and produced by the Guardian Labs team. It’s the third most common cancer in the UK, causing tens of thousands of deaths annually. But what if ...
STAT

Insmed drug benefits patients with rare, bacterial lung disease, study shows

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...